SBH
ALKS icon

Segall Bryant & Hamill’s Alkermes ALKS Stock Holding History

Segall Bryant & Hamill’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.1M Sell
498,222
-87,547
-15% -$3.42M 0.31% 96
2026
Q1 		$20.7M Sell
585,769
-29,523
-5% -$916K 0.3% 110
2025
Q4 		$17.2M Buy
615,292
+18,813
+3% +$564K 0.23% 156
2025
Q3 		$17.9M Buy
596,479
+2,541
+0.4% +$71.6K 0.24% 149
2025
Q2 		$17M Buy
593,938
+65,117
+12% +$1.94M 0.24% 147
2025
Q1 		$17.5M Sell
528,821
-40,799
-7% -$1.33M 0.27% 118
2024
Q4 		$16.4M Sell
569,620
-613,480
-52% -$17.6M 0.23% 140
2024
Q3 		$33.1M Sell
1,183,100
-37,835
-3% -$1.01M 0.45% 61
2024
Q2 		$29.4M Buy
1,220,935
+138,469
+13% +$3.4M 0.52% 55
2024
Q1 		$29.3M Sell
1,082,466
-17,787
-2% -$505K 0.55% 50
2023
Q4 		$30.5M Buy
1,100,253
+109,084
+11% +$2.83M 0.59% 44
2023
Q3 		$27.8M Buy
991,169
+8,552
+0.9% +$251K 0.32% 94
2023
Q2 		$30.8M Sell
982,617
-5,970
-0.6% -$181K 0.32% 97
2023
Q1 		$27.9M Buy
988,587
+477,352
+93% +$13M 0.3% 101
2022
Q4 		$13.4M Buy
511,235
+65,568
+15% +$1.57M 0.15% 185
2022
Q3 		$9.95M Buy
445,667
+14,606
+3% +$380K 0.12% 207
2022
Q2 		$12.8M Buy
431,061
+765
+0.2% +$22K 0.14% 168
2022
Q1 		$11.3M Buy
430,296
+1,718
+0.4% +$42.5K 0.11% 200
2021
Q4 		$9.97M Buy
428,578
+18,031
+4% +$474K 0.09% 213
2021
Q3 		$12.7M Buy
410,547
+8,198
+2% +$232K 0.12% 184
2021
Q2 		$9.87M Sell
402,349
-444
-0.1% -$9.88K 0.1% 215
2021
Q1 		$7.52M Sell
402,793
-841
-0.2% -$17.2K 0.07% 257
2020
Q4 		$8.05M Buy
403,634
+42,573
+12% +$779K 0.09% 223
2020
Q3 		$5.98M Buy
361,061
+142,129
+65% +$2.58M 0.08% 232
2020
Q2 		$4.25M Buy
218,932
+75,901
+53% +$1.23M 0.07% 236
2020
Q1 		$2.06M Buy
+143,031
New +$2.55M 0.04% 327

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Segall Bryant & Hamill's ALKS Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Alkermes (ALKS) stake by 15% in Q2 2026, selling an estimated $3.42M and leaving 498,222 shares worth $26.1M. The position accounts for 0.31% of the portfolio, ranked #96.

Segall Bryant & Hamill first reported a position in ALKS in Q1 2020 and has held it in 26 quarters since. The position peaked at $33.1M in Q3 2024. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Segall Bryant & Hamill held 498,222 shares of Alkermes worth $26.1M as of Q2 2026.
  • Segall Bryant & Hamill sold 87,547 Alkermes shares in Q2 2026, an estimated $3.42M.
  • Alkermes made up 0.31% of Segall Bryant & Hamill's portfolio in Q2 2026, its #96 holding.
  • Segall Bryant & Hamill first reported a position in Alkermes in Q1 2020 and has held it in 26 quarters since.
  • Segall Bryant & Hamill's Alkermes position peaked at $33.1M in Q3 2024.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.